This is just a glimpse. Want to receive every issue of Cannabis Wire Daily, our newsletter that is sent to subscribers each weekday morning, and unlimited access to cannabiswire.com?
California DMV is conducting a clinical trial on cannabis impairment.
The California Department of Motor Vehicles is conducting a clinical trial that aims to examine “how accurately” the “behavioral assessments used by officers” distinguishes between drivers impaired by cannabis and drivers not impaired by cannabis.
Further, the study asks “How does cannabis affect real-world (as opposed to simulated) driving performance?”
The clinical trial notice highlights that cannabis impaired driving poses several challenges. First, without a national standard to test for impairment, “it is not entirely clear how well the tools used by law enforcement officers to detect driving impairment… work for identifying cannabis-induced driving impairment specifically.” Also, these tests were found effective in an alcohol environment, which is very different from cannabis.
The study will be conducted within a “realistic, closed-course driving environment and it seeks to validate the same instruments currently used by law enforcement to detect cannabis-induced driving impairment against a second, independent, behavioral standard for driving impairment.”
The study is expected to wrap up in December 2024.
Missouri awards microbusiness licenses.
This week, Missouri’s Division of Cannabis Regulation announced that the 48 applicants who were selected in a lottery in August have been awarded licenses.
The breakdown per congressional district is six licenses, two of which are shops and four of which are wholesale facilities (these licensees can also grow).
You can see the full list of who was approved and denied in each district here. Two more lotteries will be held, in 2024 and 2025.
Adult use sales began in the state in February, as Cannabis Wire reported, when existing medical cannabis operators were able to expand.
Oral arguments scheduled for proposed adult use ballot measure.
For months now, Florida Attorney General Ashley Moody has been pushing in court against a proposed adult use measure that, if allowed to move forward, would appear on the ballot in 2024.
This week, the state’s Supreme Court scheduled oral arguments for November 8.
+ More: For more context, check out this Cannabis Wire story about Moody’s arguments, and about the unprecedented amount of money the campaign behind the measure has raised (entirely from Trulieve).
SEC goes after High Times CEO.
The Securities and Exchange Commission has filed a complaint against High Times CEO Adam Levin.
“This securities fraud enforcement action involves a scheme to conceal paid promotion of a securities offering from at least April 2020 through August 2021,” the complaint reads.
Further, “Levin violated the registration provisions of the federal securities laws. He continued the Hightimes securities offering after Hightimes was no longer eligible for the Reg A exemption and no other registration exemption applied. He also falsely represented to investors that they were purchasing Hightimes common stock for a price of $1 per share, when in fact they were purchasing for $11 per share.”
+ More: The complaint is worth reading in full, but so, too, is this op-ed written by our co-founder for Columbia Journalism Review, which touches upon the company’s IPO.